Stem cell autograft and allograft in autoimmune diseases.

about

Stem cell autograft and allograft in autoimmune diseases.

Item

http://www.wikidata.org/entity/Q38287103

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Stem cell autograft and allograft in autoimmune diseases.

@en

type

Item

label

Stem cell autograft and allograft in autoimmune diseases.

@en

prefLabel

Stem cell autograft and allograft in autoimmune diseases.

@en

P1476

Stem cell autograft and allograft in autoimmune diseases.

@en

P2093

Angela Matarangolo

http://www.w3.org/2001/XMLSchema#string

Angelo De Cata

http://www.w3.org/2001/XMLSchema#string

Michele Inglese

http://www.w3.org/2001/XMLSchema#string

Rosa Rubino

http://www.w3.org/2001/XMLSchema#string

P2860

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

Multiple sclerosis

Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Cyclophosphamide versus placebo in scleroderma lung disease.

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

P2888

s10238-014-0330-5

P304

13-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10238-014-0330-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gianluigi Mazzoccoli

P577

2014-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269520452

http://www.w3.org/2001/XMLSchema#string

P6179

1020167138

http://www.w3.org/2001/XMLSchema#string

P698

25501897

http://www.w3.org/2001/XMLSchema#string